ArticleScientific reports2025
Predicting gestational diabetes before conception for personalized interpregnancy weight management.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The growing recognition of the importance of interpregnancy care to reduce gestational diabetes mellitus (GDM) risk underscores the importance of effective preventive strategies. However, developing effective systems is still challenging. We aimed to bridge this gap by developing a weight management specific prediction model. This study retrospectively analyzed the data of women who underwent two childbirths across 15 medical facilities, including both primary and tertiary facilities. A derivation cohort was constructed using data from 2009 to 2019 (n = 1,640). Data between 2020 and 2024 was used to construct a separate temporal-validation cohort (n = 293). Using the data from another tertiary center between 2017 and 2023, the geographical-validation cohort was constructed (n = 339). A prediction model for GDM development in the second pregnancy was developed by applying logistic regression analysis using 5 key clinical information. GDM in the second pregnancy occurred in 9.5% (156 of 1,640, derivation), 16.7% (49 of 293, temporal-validation), and 7.7% (26 of 339, geographical-validation). The prediction model demonstrated consistent discrimination across cohorts, with c-statistics of 0.75, 0.80, and 0.79, respectively. Precision–recall analyses, accounting for the low prevalence of GDM, further confirmed performance well above the baseline (0.095 in the derivation cohort), with AUC-PRs of 0.43, 0.47, and 0.41 for the three cohorts. Calibration showed alignment with slopes of 1.04, 0.87, and 0.59 for each cohort. This simple and accurate model supports personalized weight management goals, offering a practical tool to reduce GDM risk in future pregnancies through inter-pregnancy weight management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.